Slayton Re

Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.

Slayton Re, Creasman Wt, Petty W et al. · PubMed · 1980 · 50 citations

Medicine, Gynecology, Oncology +11

Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents.

Bonomi Pd, J Mladineo, B Morrin et al. · PubMed · 1979 · 35 citations

Medicine, Oncology, Pharmacology +14

Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.

Slayton Re, Blessing Ja, Cynthia Angel et al. · PubMed · 1987 · 35 citations

Medicine, Gynecology, Oncology +8

Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

Slayton Re, Blessing Ja, DiSaia Pj et al. · PubMed · 1987 · 29 citations

Medicine, Gynecology, Oncology +11

Progestin therapy for advanced ovarian cancer: a phase II Eastern Cooperative Oncology Group trial.

Slayton Re, Michele Pagano, Creech Rh · PubMed · 1981 · 27 citations

Medicine, Oncology, Pharmacology +17